ARCHIVES

First-Line Tarceva Nearly Doubles PFS in EGFR-Activated Tumors

This article is from The Cancer Letter archive.

Vol. 34 No. 6 | June 24, 2011

Download PDF Visit The Full Archive

Related Articles

Funding Opportunities: RFAs For Mouse Models Consortium, Urology Research Centers

August 7, 1998

NCI to Close Clinical Branch at Frederick, Move Patients, Protocols To Bethesda

May 17, 1996

DCBD Board Votes down, Then Approves Organ Systems PA

November 10, 1989

Funding Opportunities Listed (12-page issue).

July 11, 2003

Community-Based Program Final Planning Review In August, October

August 6, 1976

In Brief: Moffitt Gets $100M From Fla. For Construction; Two Head And Neck Surgical Societies Merge

July 3, 1998